Many incumbents whose campaigns received significant brand-drug industry funding lost their races on Nov. 6. A couple of candidates who bucked the drug industry won, but advocates for lower drug prices lost a key ally in Sen. Claire McCaskill (D-MO). Among the top 20 recipients of pharma money this election cycle, eight incumbents were considered to be in competitive races. Seven of those incumbents lost: Sens. Heidi Heitkamp (D-ND), Joe Donnelly (D-IN), Dean Heller (R-NV) and McCaskill and Reps...